Literature DB >> 15467787

Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii.

Juliana L R Fietto1, Raquel S Araújo, Frederico N Valadão, Luciano G Fietto, Rogelio L Brandão, Maria J Neves, Fátima C O Gomes, Jacques R Nicoli, Ieso M Castro.   

Abstract

In this paper, comparative molecular studies between authentic Saccharomyces cerevisiae strains, related species, and the strain described as Saccharomyces boulardii were performed. The response of a S. boulardii strain and a S. cerevisiae strain (W303) to different stress conditions was also evaluated. The results obtained in this study show that S. boulardii is genetically very close or nearly identical to S. cerevisiae. Metabolically and physiologically, however, it shows a very different behavior, particularly in relation to growth yield and resistance to temperature and acidic stresses, which are important characteristics for a microorganism to be used as a probiotic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467787     DOI: 10.1139/w04-050

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  32 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Use of artificial digestive systems to investigate the biopharmaceutical factors influencing the survival of probiotic yeast during gastrointestinal transit in humans.

Authors:  Stéphanie Blanquet-Diot; Sylvain Denis; Sandrine Chalancon; Fehd Chaira; Jean-Michel Cardot; Monique Alric
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

3.  Biochemical and molecular characterization of Saccharomyces cerevisiae strains obtained from sugar-cane juice fermentations and their impact in cachaça production.

Authors:  Valdinéia Aparecida Oliveira; Maristela Araújo Vicente; Luciano Gomes Fietto; Ieso de Miranda Castro; Maurício Xavier Coutrim; Dorit Schüller; Henrique Alves; Margarida Casal; Juliana de Oliveira Santos; Leandro Dias Araújo; Paulo Henrique Alves da Silva; Rogelio Lopes Brandão
Journal:  Appl Environ Microbiol       Date:  2007-12-07       Impact factor: 4.792

4.  Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.

Authors:  Bruno Douradinha; Viviane C B Reis; Matthew B Rogers; Fernando A G Torres; Jared D Evans; Ernesto T A Marques
Journal:  Bioengineered       Date:  2013-09-05       Impact factor: 3.269

5.  A Mutation in PGM2 Causing Inefficient Galactose Metabolism in the Probiotic Yeast Saccharomyces boulardii.

Authors:  Jing-Jing Liu; Guo-Chang Zhang; In Iok Kong; Eun Ju Yun; Jia-Qi Zheng; Dae-Hyuk Kweon; Yong-Su Jin
Journal:  Appl Environ Microbiol       Date:  2018-05-01       Impact factor: 4.792

Review 6.  Saccharomyces boulardii in childhood.

Authors:  Yvan Vandenplas; Oscar Brunser; Hania Szajewska
Journal:  Eur J Pediatr       Date:  2008-12-19       Impact factor: 3.183

7.  Enterohemorrhagic Escherichia coli O157:H7 survival in an in vitro model of the human large intestine and interactions with probiotic yeasts and resident microbiota.

Authors:  Jonathan Thévenot; Lucie Etienne-Mesmin; Sylvain Denis; Sandrine Chalancon; Monique Alric; Valérie Livrelli; Stéphanie Blanquet-Diot
Journal:  Appl Environ Microbiol       Date:  2012-11-30       Impact factor: 4.792

8.  A probiotic yeast-based immunotherapy against Clostridioides difficile infection.

Authors:  Kevin Chen; Yixuan Zhu; Yongrong Zhang; Therwa Hamza; Hua Yu; Ashley Saint Fleur; James Galen; Zhiyong Yang; Hanping Feng
Journal:  Sci Transl Med       Date:  2020-10-28       Impact factor: 17.956

9.  Increased intestinal delivery of viable Saccharomyces boulardii by encapsulation in microspheres.

Authors:  Sandrine Graff; Sajjad Hussain; Jean-Claude Chaumeil; Christine Charrueau
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

10.  Effects of combined viral-bacterial challenge with or without supplementation of Saccharomyces cerevisiae boulardii strain CNCM I-1079 on immune upregulation and DMI in beef heifers.

Authors:  William Christian Kayser; Gordon E Carstens; Kevin E Washburn; Thomas H Welsh; Sara D Lawhon; Sanjay M Reddy; William E Pinchak; Eric Chevaux; Andrew L Skidmore
Journal:  J Anim Sci       Date:  2019-03-01       Impact factor: 3.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.